Patients (n = 122) | Controls (n = 58) | |
---|---|---|
Age (years) | 62 (37–86) | 62 (43–81) |
Sex (female) | 60 (49%) | 31 (53%) |
ISS stage | ||
I | 33 (27%) | |
II | 47 (39%) | |
III | 28 (23%) | |
Unknown | 14 (11%) | |
M-component | ||
IgG | 75 (61%) | |
IgA | 29 (24%) | |
Light chain | 6 (5%) | |
Unknown | 12 (10%) | |
Skeletal affection | ||
None | 12 (10%) | |
Limited | 49 (40%) | |
Osteoporosis | 9 (7%) | |
Advanced | 48 (39%) | |
Unknown | 4 (3%) |